Evaluation of serum MIP-1β and MCP-2 levels in major depressive disorder: A case-control study.
Mariya AkterA S M RoknuzzamanMohammad ShahriarSardar Mohammad Ashraful IslamMohiuddin Ahmed BhuiyanM M A Shalahuddin QusarEva Rahman KabirMd Rabiul IslamPublished in: PloS one (2024)
According to this study, elevated levels of MIP-1β and MCP-2 may be associated with the pathophysiology and development of MDD. These increased serum MIP-1β and MCP-2 levels could be used as risk assessment tools for MDD. The present findings urge further research and the development of therapeutic and diagnostic approaches for depression.